APA Цитирование

Abraham, J., Montero, A. J., Jankowitz, R. C., Salkeni, M. A., Beumer, J. H., Kiesel, B. F., . . . Jacobs, S. A. (2019). Safety and Efficacy of T-DM1 Plus Neratinib in Patients With Metastatic HER2-Positive Breast Cancer: NSABP Foundation Trial FB-10. J Clin Oncol.

Chicago-стиль цитирования

Abraham, Jame, et al. "Safety and Efficacy of T-DM1 Plus Neratinib in Patients With Metastatic HER2-Positive Breast Cancer: NSABP Foundation Trial FB-10." J Clin Oncol 2019.

MLA-цитирование

Abraham, Jame, et al. "Safety and Efficacy of T-DM1 Plus Neratinib in Patients With Metastatic HER2-Positive Breast Cancer: NSABP Foundation Trial FB-10." J Clin Oncol 2019.

Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.